Evidence map›Paper›PMID 39747156›Full record

ArticleScientific reports2025

Synergistic design of CuO/CoFe₂O₄/MWCNTs ternary nanocomposite for enhanced photocatalytic degradation of tetracycline under visible light.

Davis Varghese, Niranjana S R, Joselene Suzan Jennifer P, Muthupandi S, Madhavan J, Victor Antony Raj M

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Green Synthesis and Characterization of ZnO/CoFeMolecules (Basel, Switzerland) · 2026
    Article
  2. Z-Scheme CoFeRSC advances · 2026
    Article
  3. Facile Preparation of a Plasmon-Enhanced Ag-CuO/TiOMaterials (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Davis VargheseDepartment of Physics, Loyola College, Affiliated to the University of Madras, Chennai, 600034, India.
Niranjana S RDepartment of Physics, Panimalar Engineering College, Chennai, 600123, India.
Joselene Suzan Jennifer PDepartment of Physics, Loyola College, Affiliated to the University of Madras, Chennai, 600034, India.
Muthupandi SCenter for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Chennai, 602105, Tamil Nadu, India. muthupandisankar@gmail.com.
Madhavan JDepartment of Physics, Loyola College, Affiliated to the University of Madras, Chennai, 600034, India.
Victor Antony Raj MDepartment of Physics, Loyola College, Affiliated to the University of Madras, Chennai, 600034, India. vicvad2003@yahoo.co.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study involves a novel CuO/CoFe₂O₄/MWCNTs (CCT) nanocomposite, developed by integrating cobalt ferrite (CoFe₂O₄) and copper oxide (CuO) nanoparticles onto multi-walled carbon nanotubes (MWCNTs), for the degradation of tetracycline (TC) under visible light. The photocatalyst was extensively characterized using XRD, HR-SEM, EDX, HR-TEM, UV-Vis, BET, and PL analysis. The synthesized CoFe₂O₄ and CuO nanoparticles exhibited crystallite sizes of 46.8 nm and 37.5 nm, respectively, while the CCT nanocomposite had a crystallite size of 53 nm. Microscopy confirmed a particle size of 49.2 nm for the nanocomposite, with MWCNTs measuring 15.65 nm in diameter. The band gap energy of the CCT nanocomposite was 1.6 eV, which contributed to its enhanced photocatalytic activity, as evidenced by the lower emission intensity in PL analysis. BET analysis revealed a pore volume of 0.37 cc/g and a surface area of 82.3 m²/g. Photocatalytic performance was tested across various conditions, with adjustments to nanocomposite dosages (0.1-0.5 g/L), TC concentrations (5-25 mg/L), and pH levels (2-10). Under optimized conditions (0.3 g/L CCT, 5 mg/L TC, pH 10, 120 min of visible light exposure), the CCT achieved 98.1% degradation of TC. The optimized parameters were subsequently used to assess TC degradation with individual photocatalysts: CoFe₂O₄, CuO, CT, and CCT. The enhanced photocatalytic efficiency observed can be largely attributed to the improved charge transfer dynamics and effective electron-hole separation facilitated by MWCNT doping. The reaction followed a pseudo-first-order kinetic model, with hydroxyl radicals (OH

Indexed as

CuO/CoFe2O4/MWCNTsDegradation kineticsPhotocatalysisTetracyclineVisible light

Identifiers

PMID39747156
PMCPMC11696163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.